Plasma Protein Profile Associated With a Family History of Early-Onset Coronary Heart Disease

Agnes Wahrenberg1, Lars Lind2,3, Natan Åberg1

  • 1Department of Clinical Science and Education, Södersjukhuset (A.W., N.Å., P.S.), Karolinska Institutet, Stockholm, Sweden.

Insights

This study identifies 38 proteins associated with a family history of early-onset coronary heart disease (CHD), revealing new insights into atherosclerosis mechanisms. Key proteins like cathepsin D and follistatin highlight potential pathways for heritable heart disease.

Area of Science:

  • Cardiovascular Science
  • Proteomics
  • Genetics

Background:

  • Heritable coronary heart disease (CHD) may involve novel pathophysiological mechanisms in atherosclerosis.
  • Understanding the protein profile associated with family history of early-onset CHD is crucial.

Purpose of the Study:

  • To investigate the protein profile associated with family history of early-onset CHD.
  • To determine if protein-atherosclerosis relationships differ by family history status.
  • To explore causal associations using Mendelian randomization.

Main Methods:

  • Utilized computed tomography angiography and Olink proteomics on 4521 subjects from the SCAPIS study.
  • Retrieved family history data from national registers.
  • Performed Mendelian randomization using genome-wide association study data from UKB-PPP, CARDIoGRAMplusC4D, and FinnGen.

Main Results:

  • Identified 38 proteins associated with family history of early-onset CHD, including cathepsin D, paraoxonase 3, renin, and follistatin.
  • Eighteen proteins interacted with family history in relation to coronary atherosclerotic burden, notably LDL receptor and PECAM1.
  • Mendelian randomization revealed a novel association for follistatin with myocardial infarction and confirmed associations for PCSK9 and PECAM1.

Conclusions:

  • Findings suggest new potential mechanisms underlying heritable and general atherosclerosis.
  • The identified proteins offer novel targets for understanding and potentially treating atherosclerosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
525
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
200
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
355
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
313
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380